John Kagia works at New Frontier Data as the Chief Knowledge Officer. They have a new report on cannabis and the pharmaceutical industry, and the destruction cannabis is bound to cause. (You can view a copy of that report at: https://newfrontierdata.com/analyst-reports/ ). The report covers the expansion of the legalization on a state basis for both medical and recreational marijuana, what that means to consumers. The report also analyzes the effects of possibly forthcoming federal decriminalization. Cannabis products could 'cannibalize' convention products currently in use by competing with them, or replacing some altogether. Decriminalization would likely allow commerce between states and even shipments outside of our borders. This will inevitably bring reductions in the prices of cannabis. Amid all of this, pharmaceutical companies themselves would be prone to venture into growing and marketing marijuana themselves. Hear all the details in this insightful interview that might foretell our near future.
Find more at: https://w420radionetwork.com/s3-e10-legalization-effects-investment-analysis-sensi-magazine-varied-product-demands/
